TTP plc: TTP Introduces Cellular Origins, a TTP Company Focussed on Delivering Scalable Manufacture of Cell and Gene Therapies
New company created to enable commercial manufacture of new cell and gene therapies Cellular Origins' proprietary technology will address current barriers associated with cost-effective and
Kostenloser Wertpapierhandel Matthew Carr Lorna Cuddon Zyme Communications Automation Technology To Enhance Development Head Of Life Sciences
Source: finanznachrichten.de